U.S., March 22 -- ClinicalTrials.gov registry received information related to the study (NCT06888193) titled 'A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx(R) (Bimekizumab)' on March 15.
Brief Summary: Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.
Study Start Date: April 07
Study Type: INTERVENTIONAL
Condition:
Moderate to Severe Plaque Psoriasis
Psoriatic Arthritis
Axial Spondyloarthritis
Hidradenitis Suppurativa
Intervention:
DRUG: Bimekizumab
Bimekizumab under the care of their treating physician.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: UCB Biopharma SRL
Published by HT Digital Content Serv...